Periprosthetic osteolysis: a narrative review.

RANK-RANKL growth factors osteoimmunology periprosthetic osteolysis

Journal

Journal of biological regulators and homeostatic agents
ISSN: 0393-974X
Titre abrégé: J Biol Regul Homeost Agents
Pays: Italy
ID NLM: 8809253

Informations de publication

Date de publication:
Historique:
entrez: 2 12 2020
pubmed: 3 12 2020
medline: 29 1 2021
Statut: ppublish

Résumé

Periprosthetic osteolysis is still one of the major limitations of prosthetic joints longevity. The process of this "silent" iatrogenic disease involves both mechanical and biological factors that initiate a local immune response in the periprosthetic tissue that eventually lead to implant loosening and failure. There are many causes of the primary aseptic loosening inside the periprosthetic microenvironment, but the most important elements are the wear debris and the cell-particle interactions. Together with implant position, micromotion, bearings, joint fluid pressure, and increased load on the joints drive the pathogenesis of the disease. This narrative review aims to summarise recent studies describing the biological and mechanical factors in the pathogenesis of osteolysis and some of the current pharmacological attempts to "rescue" a failing implant.

Identifiants

pubmed: 33261304
pii: 55

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

405-417. Congress of the Italian Orthopaedic Research Society

Informations de copyright

Copyright 2020 Biolife Sas. www.biolifesas.org.

Auteurs

A Marmotti (A)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.
Molecular Biotechnology Center, University of Turin, Torino, Italy.

D Messina (D)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.

A Cykowska (A)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.

C Beltramo (C)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.

E Bellato (E)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.

D Colombero (D)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.

G Agati (G)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.

L Mangiavini (L)

IRCCS Istituto Ortopedico Galeazzi, Milano, Italy.
Department of Biomedical Sciences for Health, University of Milan, Milano, Italy.

M Bruzzone (M)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.

F Dettoni (F)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.

G M Peretti (GM)

IRCCS Istituto Ortopedico Galeazzi, Milano, Italy.
Department of Biomedical Sciences for Health, University of Milan, Milano, Italy.

F Castoldi (F)

Department of Orthopaedics and Traumatology, University of Turin, Torino, Italy.
Molecular Biotechnology Center, University of Turin, Torino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH